RMTI Rockwell Medical, Inc.
Healthcare$0.76-4.74%ClosedMarket Cap: $29.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.87
P/S
0.46
EV/EBITDA
-13.91
DCF Value
$-3.98
FCF Yield
5.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
17.1%
Operating Margin
-7.1%
Net Margin
-8.0%
ROE
-15.4%
ROA
-9.4%
ROIC
-9.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $17.3M | 16.7% | $-1.5M | $-1.6M | $— | — |
| Q4 null | $18.3M | 21.1% | $-398.0K | $-554.0K | $— | — |
| FY null | $69.3M | 16.9% | $-4.7M | $-5.3M | $— | — |
| Q3 null | $15.9M | 14.3% | $-1.6M | $-1.8M | $— | — |
| Q2 null | $16.1M | 15.6% | $-1.3M | $-1.5M | $— | — |
| Q1 null | $18.9M | 16.1% | $-1.4M | $-1.5M | $— | — |
| Q4 null | $24.7M | 14.7% | $-519.0K | $-756.0K | $— | — |
| FY null | $101.5M | 17.2% | $608.0K | $-480.0K | $— | — |
| Q3 null | $28.3M | 22.0% | $1.9M | $1.7M | $— | — |
| Q2 null | $25.8M | 17.6% | $515.0K | $343.0K | $— | — |
| Q1 null | $22.7M | 13.5% | $-1.3M | $-1.7M | $— | — |
| Q4 2023 | $22.1M | 13.0% | $-547.0K | $-1.5M | $-0.05 | — |